1. Home
  2. NKTX vs ACR Comparison

NKTX vs ACR Comparison

Compare NKTX & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • ACR
  • Stock Information
  • Founded
  • NKTX 2015
  • ACR 2005
  • Country
  • NKTX United States
  • ACR United States
  • Employees
  • NKTX N/A
  • ACR N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • ACR Real Estate Investment Trusts
  • Sector
  • NKTX Health Care
  • ACR Real Estate
  • Exchange
  • NKTX Nasdaq
  • ACR Nasdaq
  • Market Cap
  • NKTX 123.5M
  • ACR 139.0M
  • IPO Year
  • NKTX 2020
  • ACR N/A
  • Fundamental
  • Price
  • NKTX $2.37
  • ACR $21.04
  • Analyst Decision
  • NKTX Strong Buy
  • ACR Buy
  • Analyst Count
  • NKTX 5
  • ACR 2
  • Target Price
  • NKTX $13.50
  • ACR $17.50
  • AVG Volume (30 Days)
  • NKTX 556.1K
  • ACR 24.4K
  • Earning Date
  • NKTX 08-12-2025
  • ACR 07-30-2025
  • Dividend Yield
  • NKTX N/A
  • ACR N/A
  • EPS Growth
  • NKTX N/A
  • ACR N/A
  • EPS
  • NKTX N/A
  • ACR 0.04
  • Revenue
  • NKTX N/A
  • ACR $86,599,000.00
  • Revenue This Year
  • NKTX N/A
  • ACR $3.57
  • Revenue Next Year
  • NKTX N/A
  • ACR N/A
  • P/E Ratio
  • NKTX N/A
  • ACR $462.56
  • Revenue Growth
  • NKTX N/A
  • ACR 12.74
  • 52 Week Low
  • NKTX $1.31
  • ACR $14.87
  • 52 Week High
  • NKTX $6.63
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 64.66
  • ACR 78.09
  • Support Level
  • NKTX $2.23
  • ACR $18.67
  • Resistance Level
  • NKTX $2.50
  • ACR $20.58
  • Average True Range (ATR)
  • NKTX 0.13
  • ACR 0.42
  • MACD
  • NKTX 0.02
  • ACR 0.07
  • Stochastic Oscillator
  • NKTX 76.85
  • ACR 94.22

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: